Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 4209257, 8 pages
https://doi.org/10.1155/2017/4209257
Research Article

Association of GCLM -588C/T and GCLC -129T/C Promoter Polymorphisms of Genes Coding the Subunits of Glutamate Cysteine Ligase with Ischemic Heart Disease Development in Kazakhstan Population

1Institute of General Genetics and Cytology, Al-Farabi St. 93, Almaty, Kazakhstan
2Russian Medical University, Torekulovst 71, Almaty, Kazakhstan
3Leonard Davis School of Gerontology, University of Southern California, 3715 McClintock Avenue, Los Angeles, CA 90089, USA

Correspondence should be addressed to Liliya Skvortsova; ur.relbmar@555_ailil

Received 16 February 2017; Revised 31 May 2017; Accepted 8 June 2017; Published 5 July 2017

Academic Editor: Mariann Harangi

Copyright © 2017 Liliya Skvortsova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Operational data (express information, bulletins), (n.D.),” May 2017, http://www.stat.gov.kz/faces/publicationsPage/publicationsOper?_adf.ctrl-state=rth4h7a2y_59&_afrLoop=919058021394864&visiblescreen=no&page_id=publicationsOper.
  2. S. De Rosa, P. Cirillo, A. Paglia, L. Sasso, V. Di Palma, and M. Chiariello, “Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach?” Current Vascular Pharmacology, vol. 8, pp. 259–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Aviram, “Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases,” Free Radical Research, vol. 33, pp. S85–S97, 2000. View at Google Scholar
  4. K. K. Griendling, D. Sorescu, B. Lassegue, and M. Ushio-Fukai, “Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, pp. 2175–2183, 2000. View at Publisher · View at Google Scholar
  5. V. I. Kulinsky and L. S. Kolesnichenko, “The glutathione system. I. Synthesis, transport, glutathione transferases, glutathione peroxidases,” Biochemistry (Moscow) Supplement Series B Biomedical Chemistry, vol. 3, pp. 129–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Meister, “Glutathione biosynthesis and its inhibition,” Methods in Enzymology, vol. 252, pp. 26–30, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. G. F. Seelig, R. P. Simondsen, and A. Meister, “Reversible dissociation of γ-glutamylcysteine synthetase into two subunits,” The Journal of Biological Chemistry, vol. 259, pp. 9345–9347, 1984. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Wild and R. Mulcahy, “Regulation of gamma-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defenses,” Free Radical Research, vol. 32, pp. 281–301, 2000. View at Publisher · View at Google Scholar
  9. K. Saify, I. Saadat, and M. Saadat, “Influence of A-21T and C-262T genetic polymorphisms at the promoter region of the catalase (CAT) on gene expression,” Environmental Health and Preventive Medicine, vol. 21, pp. 382–386, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. I. Nakamura, K. Kugiyama, S. Sugiyama et al., “Polymorphism in the 5′-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction,” Circulation, vol. 105, pp. 2968–2973, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. I. Koide, K. Kugiyama, S. Sugiyama et al., “Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction,” Journal of the American College of Cardiology, vol. 41, pp. 539–545, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Butticaz, R. Gysin, M. Cuénod, and K. Q. Do, “Interaction of GAG trinucleotide repeat and C - 129 T polymorphisms impairs expression of the glutamate-cysteine ligase catalytic subunit gene,” Free Radical Biology and Medicine, vol. 50, pp. 617–623, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Campolo, S. Penco, E. Bianchi et al., “Glutamate-cysteine ligase polymorphism, hypertension, and male sex are associated with cardiovascular events. Biochemical and genetic characterization of Italian subpopulation,” American Heart Journal, vol. 154, pp. 1123–1129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. V. Polonikov, V. P. Ivanov, M. A. Solodilova, I. V. Khoroshaya, M. A. Kozhuhov, and V. I. Panfilov, “The relationship between polymorphisms in the glutamate cysteine ligase gene and asthma susceptibility,” Respiratory Medicine, vol. 101, pp. 2422–2424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Katakami, K. Sakamoto, H. Kaneto et al., “Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis,” Biochemical and Biophysical Research Communications, vol. 379, pp. 861–865, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Campeau, “Letter: grading of angina pectoris,” Circulation, vol. 54, pp. 522-523, 1976, http://circ.ahajournals.org/content/54/3/522.2. View at Google Scholar
  17. “Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature,” Circulation, vol. 59, pp. 607–609, 1979. View at Publisher · View at Google Scholar
  18. N. Ballatori, S. M. Krance, S. Notenboom, S. Shi, K. Tieu, and C. L. Hammond, “Glutathione dysregulation and the etiology and progression of human diseases,” Biological Chemistry, vol. 390, pp. 191–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. de Andrade, Y. Li, R. S. Marks et al., “Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer,” Cancer Prevention Research (Philadelphia, Pa.), vol. 5, pp. 365–373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Gysin, R. Kraftsik, J. Sandell et al., “Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, pp. 16621–16626, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. P. M. S. Oliveira, J. T. Stefano, A. M. Cavaleiro et al., “Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease,” Journal of Gastroenterology and Hepatology, vol. 25, pp. 357–361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. I. Nakamura, S. Sugiyama, D. Fujioka, K. I. Kawabata, H. Ogawa, and K. Kugiyama, “Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function,” Circulation, vol. 108, pp. 1425–1427, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. Vieira, M. B. Monteiro, T. Marques et al., “Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus,” BMC Medical Genetics, vol. 12, p. 129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. E. F. McKone, J. Shao, D. D. Frangolias et al., “Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease,” American Journal of Respiratory and Critical Care Medicine, vol. 174, pp. 415–419, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kawabata, T. Kobayashi, D. Fujioka et al., “Abstract 9208: association of polymorphism in glutamate-cysteine ligase modifier subunit gene with idiopathic dilated cardiomyopathy,” Circulation, vol. 124, 2011, http://circ.ahajournals.org/content/124/Suppl_21/A9208.full. View at Google Scholar
  26. Y. Watanabe, K. Watanabe, T. Kobayashi et al., “Chronic depletion of glutathione exacerbates ventricular remodelling and dysfunction in the pressure-overloaded heart,” Cardiovascular Research, vol. 97, pp. 282–292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. K. S. Engström, M. Wennberg, U. Strömberg et al., “Evaluation of the impact of genetic polymorphisms in glutathione-related genes on the association between methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction: a case-control study,” Environmental Health, vol. 10, p. 33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Muehlhause, S. Kropf, and A. Gardemann, “C–588T polymorphism of the human glutamate-cysteine ligase modifier subunit gene is not associated with the risk and extent of ischemic heart disease in a German cohort,” Clinical Chemistry and Laboratory Medicine, vol. 45, pp. 1416–1418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. Mansego, G. D. M. Solar, M. P. Alonso et al., “Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension,” Journal of Hypertension, vol. 29, pp. 492–500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Nguyen, P. J. Sherratt, and C. B. Pickett, “Regulatory mechanisms controlling gene expression mediated by the antioxidant response element,” Annual Review of Pharmacology and Toxicology, vol. 43, pp. 233–260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Mani, S. Khaghani, T. Gol Mohammadi et al., “Activation of Nrf2-antioxidant response element mediated glutamate cysteine ligase expression in hepatoma cell line by homocysteine,” Hepatitis Monthly, vol. 13, no. article e8394, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Moi, K. Chan, I. Asunis, A. Cao, and Y. W. Kan, “Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, pp. 9926–9930, 1994, http://www.ncbi.nlm.nih.gov/pubmed/7937919. View at Google Scholar
  33. S. Levy and H. J. Forman, “C-Myc is a Nrf2-interacting protein that negatively regulates phase II genes through their electrophile responsive elements,” IUBMB Life, vol. 62, pp. 237–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. R. T. Mulcahy and J. J. Gipp, “Identification of a putative antioxidant response element in the 5′-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene,” Biochemical and Biophysical Research Communications, vol. 209, pp. 227–233, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. S. N. Nichenametla, P. Lazarus, and J. P. Richie, “A GAG trinucleotide-repeat polymorphism in the gene for glutathione biosynthetic enzyme, GCLC, affects gene expression through translation,” The FASEB Journal, vol. 25, pp. 2180–2187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. “Reference SNP (refSNP) cluster report: rs41303970, (n.D.),” May 2017, https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41303970.
  37. M. B. Khadzhieva, N. N. Lutcenko, I. V. Volodin, K. V. Morozova, and L. E. Salnikova, “Association of oxidative stress-related genes with idiopathic recurrent miscarriage,” Free Radical Research, vol. 48, pp. 534–541, 2014. View at Publisher · View at Google Scholar · View at Scopus